683 Capital Management, LLC Q3 2021 Filing
Filed November 15, 2021
Portfolio Value
$2.6T
Holdings
214
Report Date
Q3 2021
Filing Type
13F-HR
All Holdings (214 positions)
| Stock | Value |
|---|---|
AMCAMC ENTMT HLDGS INC | $344.0B |
CVNACARVANA CO | $164.3B |
CDLXCARDLYTICS INC | $123.0B |
GMGENERAL MTRS CO | $116.0B |
ENVAENOVA INTL INC | $105.3B |
FEFIRSTENERGY CORP | $88.7B |
HLFHERBALIFE NUTRITION LTD | $83.2B |
TMTOYOTA MOTOR CORP | $53.3B |
WEPMAGELLAN MIDSTREAM PRTNRS LP | $46.9B |
PCGPG&E CORP | $42.6B |
OPENOPENDOOR TECHNOLOGIES INC | $41.1B |
0J7QIAC INTERACTIVECORP NEW | $40.0B |
UCOPROSHARES TR II | $37.9B |
ADNTADIENT PLC | $37.7B |
SFIXSTITCH FIX INC | $37.2B |
GLPGGALAPAGOS NV | $36.9B |
—AFFIMED N V | $34.6B |
GMEGAMESTOP CORP NEW | $32.5B |
QSQUANTUMSCAPE CORP | $31.9B |
ATRAGBXATARA BIOTHERAPEUTICS INC | $31.9B |
SDCCQSMILEDIRECTCLUB INC | $31.3B |
AMZNAMAZON COM INC | $29.6B |
TDWDTAILWIND ACQUISITION CORP | $29.3B |
ANGI1EURANGI INC | $28.0B |
TGTXTG THERAPEUTICS INC | $27.6B |
CNDACONCORD ACQUISITION CORP II | $24.7B |
—SQZ BIOTECHNOLOGIES CO | $24.4B |
IOVAIOVANCE BIOTHERAPEUTICS INC | $23.4B |
QUREUNIQURE NV | $22.8B |
MRNS*MARINUS PHARMACEUTICALS INC | $22.0B |
SNDXSYNDAX PHARMACEUTICALS INC | $21.7B |
—CONCORD ACQUISITION CORP | $21.7B |
CLDNEUREIGER BIOPHARMACEUTICALS INC | $21.2B |
SLVISHARES SILVER TR | $20.5B |
PRGPROG HOLDINGS INC | $20.2B |
INSEINSPIRED ENTMT INC | $20.1B |
—DIRTT ENVIRONMENTAL SOLUTION | $19.5B |
—TPG PACE SOLUTIONS CORP | $19.4B |
—TIO TECH A | $19.3B |
—LOGISTICS INNOVTN TECHNLGS C | $18.5B |
MGTXMEIRAGTX HLDGS PLC | $17.3B |
MHLAMAIDEN HOLDINGS LTD | $16.3B |
—HORIZON ACQUISITION CORP | $16.0B |
—ALKURI GLOBAL ACQUISITION CO | $15.7B |
IMTXIMMATICS N.V | $15.4B |
—ROCKET INTERNET GRWT OPRT CO | $14.7B |
—KHOSLA VENTURES ACQUSTN CO I | $14.5B |
—PANACEA ACQUISITION CORP II | $14.5B |
IRSUSDIRSA INVERSIONES Y REP S A | $14.0B |
—MONTES ARCHIMEDES ACQUISITIO | $12.0B |
—FIRST LT ACQUISITION GROUP I | $11.9B |
DHTDHT HOLDINGS INC | $11.9B |
—SARISSA CAPITAL ACQUISITN CO | $11.8B |
—ORION BIOTECH OPPORTUNTES CO | $11.8B |
CUECUE BIOPHARMA INC | $10.8B |
FRXFENNEC PHARMACEUTICALS INC | $10.5B |
—BROADSTONE ACQUISITION CORP | $10.1B |
ABXBARRICK GOLD CORP | $10.0B |
—DFP HEALTHCARE ACQUISITNS CO | $9.9B |
—AXONPRIME INFRSTCTR AQSTN CO | $9.9B |
—BRIDGETOWN HOLDINGS LTD | $9.8B |
—MACONDRAY CAP ACQUISITN CORP | $9.8B |
—NOCTURNE ACQUISITION CORP | $9.5B |
—BRIDGETOWN 2 HOLDINGS LTD | $9.4B |
ALNYALNYLAM PHARMACEUTICALS INC | $9.3B |
XERS 5 07/15/25XERIS PHARMACEUTICALS INC | $9.1B |
—ARYA SCIENCES ACQUISITN CORP | $8.9B |
CD8CRESUD S A C I F Y A | $8.8B |
—SOFTWARE ACQUISITN GRP INC I | $7.8B |
—IRSA PROPIEDADES COMERCIALES | $7.7B |
HOODROBINHOOD MKTS INC | $6.9B |
—APTOSE BIOSCIENCES INC | $6.8B |
CMBTEURONAV NV | $6.2B |
—EUCRATES BIOMEDICAL ACQU COR | $5.9B |
CMPRCIMPRESS PLC | $5.9B |
SHLXUSDSHELL MIDSTREAM PARTNERS L P | $5.7B |
5E7ITEOS THERAPEUTICS INC | $5.4B |
—NEXTGEN ACQUISITION CORP II | $5.3B |
DEODIAGEO PLC | $5.3B |
—LIBERTY MEDIA ACQUISITION CO | $5.1B |
—ARGUS CAPITAL CORP | $5.1B |
—REINVENT TECHNOLOGY PARTNERS | $5.0B |
—GRAF ACQUISITION CORP IV | $4.8B |
—GIGINTERNATIONAL1 INC | $4.7B |
—DMY TECHNOLOGY GROUP INC III | $4.7B |
—GORES GUGGENHEIM INC | $4.7B |
—VECTOIQ ACQUISITION CORP II | $4.4B |
—FORESIGHT ACQUISITION CORP | $3.9B |
—PROVIDENT ACQUISITION CORP | $3.9B |
TYGOROTH CH ACQUISITION IV CO | $3.8B |
CFRXUSDCONTRAFECT CORP | $3.3B |
—WILLIAMS ROWLAND ACQUISITION | $3.2B |
CUROEURCURO GROUP HOLDINGS CORP | $3.1B |
—BETTER WORLD ACQUISITION COR | $3.0B |
—ARYA SCIENCES ACQU CORP IV | $3.0B |
—GLOBIS ACQUISITION CORP | $3.0B |
LRMRLARIMAR THERAPEUTICS INC | $3.0B |
—D AND Z MEDIA ACQUISITION CO | $2.9B |
WVEWAVE LIFE SCIENCES LTD | $2.8B |
VMEO*VIMEO INC | $2.7B |
Page 1 of 3Next